UNAIDS encourages commitment to creating HIV vaccine
Thanks to vaccines, smallpox has been entirely eliminated, and polio is nearly eradicated. Vaccines control mumps, pertussis, diphtheria, tetanus, rubella, measles and other similar diseases.
2013 showed the steepest decline in investments for HIV vaccine research and development since 2008. Resources must be sustained in order to find an effective HIV vaccine.
Health professionals consider vaccines to be especially advantageous as they can be implemented effectively in all settings and communities around the world, even in areas where health services are more difficult to provide to citizens who need treatments. Vaccines also promote equity throughout these same communities.
Studies have suggested that a vaccine for HIV has potential. In 2009, the RV144 vaccine trial reduced HIV infection rates by 31 percent. There is still ongoing research that is furthering the results found in this initial trial. Other vaccine candidates involve neutralizing antibodies.
“A vaccine would be a major step towards ending the AIDS epidemic,” UNAIDS Executive Director Michel Sidibé said. “There have been encouraging recent scientific advances that give us hope for the future development of an HIV vaccine.”